Advanced Search

Oncology & Hematology Coding Alert

CMS News:

CMS Update: You Can Hope To Refine Your Biosimilar Coding

Published on Thu Aug 20, 2015

Medicare to adopt common J codes for biosimilar and reference biologic drugs. The Centers for Medicare & Medicaid Services (CMS) is expected to incorporate biosimilars that are approved under the abbreviated biological approval pathway into the average sales price (ASP) payment methodology. According to guidance from CMS earlier this year, Medicare was to pay 106 percent of the manufacturer’s wholesale [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All